2017 Annual Meeting

Vendor Supported Events


Vendor-supported symposia, which have been made possible through marketing support, will be offered on Thursday and Friday evening, as well as Saturday morning during the meeting. Details on these vendor-supported symposia is listed below and will be mailed to members and meeting registrants as soon as they are available.

NOTE: Vendor satellite symposia are supported by specific companies and are supported through a marketing grant. They are not part of the official program of the ASBrS and are free to all registered attendees.

THURSDAY EVENING SYMPOSIUM

Thursday, April 27
5:30 pm–7:30 pm

Genomic Health, Inc.
Grand Ballroom
This event will be held immediately following the Coding and Reimbursement Symposium in the same room. 

Genomic Assays and Patient Outcomes: Real-world Applications

Overall Program Objective: To offer perspectives on the analysis of outcomes data and their application in the choice of genomic assays for patients with early-stage breast cancer to enable informed treatment planning.

Description of Program: This program will feature a moderated panel discussion with 3-4 physician speakers presenting a range of patient cases and the implications of using genomic classifiers in the management of early-stage breast cancer. The program will also include a review and analysis of several key studies with outcomes data, eg TAILORx Trial, SEER and Clalit Breast Cancer Registry (Israel), and restaging using the 8th Edition of the AJCC Cancer Staging Manual. 

How to Register: Please click the following link to register: Genomic Health Symposium Registration.

NOTE: This satellite symposium is supported by Genomic Health, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Friday evening Symposia

Friday, April 28
Satellite Symposia
7:30 pm–9:30 pm

Genentech, Inc.
Invuity, Inc.
Myriad Genetics, Inc.


Genentech, Inc.

Information will be provided as soon as available.

NOTE: This satellite symposium is supported by Genentech, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Invuity, Inc.

Hidden Scar Breast Cancer Surgery: Advanced Techniques and Technologies Program

Objective: Clinical instruction on Hidden Scar Breast Cancer Surgery – attendees will leave with an understanding of patient indications, techniques and assistive technologies for these procedures

Description of Program: Discuss indications and techniques for Hidden Scar approaches to Nipple Sparing Mastectomy and Breast Conserving Surgery, and the impact of these approaches on a patient's oncologic outcome, emotional and psychological recovery, and quality of life post-surgery.

How to Register: Please contact Sandy Takayoshi-Berta at stakayoshiberta@invuity.com for more information.

NOTE: This satellite symposium is supported by Invuity, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Myriad Genetics, Inc.

The Future of Breast Cancer Recurrence Testing – A Scientific Introduction to EndoPredict

Program Objectives:
Participants will gain an understanding of the clinical benefits of Myriad’s EndoPredict breast cancer recurrence test. During the symposium, participants will learn about the scientific development and clinical validation of EndoPredict, as well as clinical application of the EndoPredict test result. EndoPredict predicts early and late recurrence risk for patients with ER+, HER2- early stage breast cancer and up to 3 positive lymph nodes.

Description of Program:
EndoPredict is a breast cancer recurrence test for patients diagnosed with ER+, HER2- early stage breast cancer with up to 3 positive lymph nodes that was validated in over 4,000 patients. . This program will explore the data supporting the use of EndoPredict to assess the risk of distant metastases in years 0 to 10 post diagnosis when treated with 5 years of endocrine therapy. EndoPredict is a provided by Myriad Genetics Laboratories, a leader in molecular diagnostic testing.

How to Register: Please click the following link to register: The Future of Breast Cancer Recurrence Testing – A Scientific Introduction to EndoPredict RSVP

NOTE: This satellite symposium is supported by Myriad Genetics Laboratories, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


 

Saturday Breakfast Symposia

Saturday, April 129
6:15 am–7:45 am

Programs:
    Albert Einstein College of Medicine
    BioTheranostics, Inc.
    Cianna Medical
    Dune Medical Devices
    Focal Therapeutics
    ImpediMed, Inc. 

 

Albert Einstein College of Medicine

Virtual Cadaver Hand-On Workshop: Identifying Breast and Abdominal Planes for Surgical Infiltration to Manage Post-Surgical Pain

Overall Program Objectives:

  • Describe the opioid epidemic and associated adverse events with opioids.
  • Review the multimodal options utilized pre-op, inter-op and post-op in breast reconstruction surgery.
  • Identify the surgical anatomy targeting PECS I, II, III, serratus, classic tap, subcostal and rectus sheath blocks.
  • Adapt techniques via hands-on practice on live models and phantom stations.

Brief Description of Program:
The symposium will include a faculty presentation, questions and answers and a hands-on workshop. It will provide the learners with the opportunity to interact with faculty in real time.

How to Register: Please click the following link to register: www.eeds.com/live/860750. For more information, please contact Stacy Atkinson at statkins@montefiore.org or 718-920-6674.

Note: This satellite symposium is supported by Pacira Pharmaceuticals through an educational grant provided to Albert Einstein College of Medicine. CME credits for this program will be provided by Albert Einstein College of Medicine. It is not part of the official program of the ASBrS*. This activity is free to all registered attendees. (*An independent grant from Albert Einstein College of Medicine was provided to the ASBrS in order to offer this satellite symposium during the 18th Annual Meeting.)


BioTheranostics
Information will be provided as soon as available.

NOTE: This satellite symposium is supported by BioTheranostics, through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Cianna Medical
Information will be provided as soon as available.

NOTE: This satellite symposium is supported by Cianna Medical, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Dune Medical Devices
Information will be provided as soon as available.

For more information or if you would like to speak with someone from Dune directly please send and email to Whitney Hausmann at whitney.hausmann@dunemedical.com

NOTE: This satellite symposium is supported by Dune Medical Devices, Inc. through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Focal Therapeutics, Inc.

Improving Your Outcomes with Oncoplastic Surgery: Techniques in "Reconstructive Lumpectomy"

Brief Description of Program:
Topics will include principles and practice of oncoplastic breast conserving surgery with specific attention focused on "reconstructive lumpectomy".  Integration of the BioZorb implant will be covered including tips on patient selection, surgical techniques, and other "pearls" on how to optimize patient outcomes.  Impact on radiation therapy and coding for oncoplastic surgery will also be addressed.

HOW TO REGISTER:  Please RSVP to kmurray@focalrx.com.

NOTE: This satellite symposium is supported by Focal Therapeutics through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


ImpediMed, Inc. 
Information will be provided as soon as available.

NOTE: This satellite symposium is supported by ImpediMed, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


back